Via Takeda
“Experts from the world’s leading plasma companies have come together to create a new alliance aimed at treating the new coronavirus. The CoVIg-19 Plasma Alliance is an initiative to accelerate the development of a potential treatment for COVID-19. The first phase of the Alliance is collecting plasma at licensed plasma collection centers across the U.S. from healthy individuals who have recovered from COVID-19. Known as convalescent plasma, the plasma of recovered COVID-19 patients contains critical antibodies that could be used to make an experimental treatment. The “I” and “g” in CoVIg-19 stand for immune globulin, which the CoVIg-19 Plasma Alliance will use to concentrate the antibodies into an investigational medicine.”
“The CoVIg-19 Plasma Alliance includes the leading-edge expertise of Biotest, BPL, LFB, and Octapharma along with CSL Behring and Takeda who formed the alliance. The Bill & Melinda Gates Foundation is serving as an advisory partner. Microsoft is providing technology including the Alliance website and the Plasma Bot for donor recruitment. Experts from the Alliance are collaborating across key aspects such as plasma collection, clinical trial development, and product manufacturing.”
See how you can help the CoVIg-19 Plasma Alliance
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.
